#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4727603	Binding	Inhibition of human SGLT1 expressed in CHO cells assessed as reduction in [14C]-methyl-alpha -D-glucopyranoside accumulation	Homo sapiens	12	ALA4725317	cell-based format	Scientific Literature
2.	ALA4727604	Binding	Inhibition of human SGLT2 expressed in CHO cells assessed as reduction in [14C]-methyl-alpha -D-glucopyranoside accumulation	Homo sapiens	12	ALA4725317	cell-based format	Scientific Literature
3.	ALA4727607	ADME	Stability of compound in human liver microsomes assessed as parent compound remaining at 1 uM measured at 10 mins in presence of NADPH	Homo sapiens	11	ALA4725317	microsome format	Scientific Literature
4.	ALA4727609	ADME	Stability of compound in mouse liver microsomes assessed as parent compound remaining at 1 uM measured at 10 mins in presence of NADPH	Mus musculus	11	ALA4725317	microsome format	Scientific Literature
5.	ALA4727610	ADME	Stability of compound in rat liver microsomes assessed as parent compound remaining at 1 uM measured at 10 mins in presence of NADPH	Rattus norvegicus	11	ALA4725317	microsome format	Scientific Literature
6.	ALA4727611	ADME	Clearance in Sprague-Dawley rat at 2 mg/kg, iv or 10 mg/kg, po	Rattus norvegicus	4	ALA4725317	organism-based format	Scientific Literature
7.	ALA4727612	ADME	Volume of distribution at steady state in Sprague-Dawley rat at 2 mg/kg, iv or 10 mg/kg, po	Rattus norvegicus	4	ALA4725317	organism-based format	Scientific Literature
8.	ALA4727613	ADME	Half life in Sprague-Dawley rat at 2 mg/kg, iv	Rattus norvegicus	4	ALA4725317	organism-based format	Scientific Literature
9.	ALA4727614	ADME	AUC (0 to infinity) in Sprague-Dawley rat at 2 mg/kg, iv or 10 mg/kg, po	Rattus norvegicus	3	ALA4725317	organism-based format	Scientific Literature
10.	ALA4727615	ADME	Cmax in Sprague-Dawley rat at 2 mg/kg, iv or 10 mg/kg, po	Rattus norvegicus	4	ALA4725317	organism-based format	Scientific Literature
11.	ALA4727616	ADME	Tmax in Sprague-Dawley rat at 2 mg/kg, iv or 10 mg/kg, po	Rattus norvegicus	4	ALA4725317	organism-based format	Scientific Literature
12.	ALA4727617	ADME	Oral bioavailability in Sprague-Dawley rat at 10 mg/kg	Rattus norvegicus	4	ALA4725317	organism-based format	Scientific Literature
13.	ALA4727625	Functional	Hypoglycemic activity in overnight fasted Sprague-Dawley rat assessed as percent reduction in blood glucose AUC at 1 mg/kg, po measured after 4 hrs post glucose challenge by OGTT relative to control	Rattus norvegicus	3	ALA4725317	organism-based format	Scientific Literature
14.	ALA4727626	Functional	Hypoglycemic activity in overnight fasted Sprague-Dawley rat assessed as percent reduction in blood glucose AUC at 10 mg/kg, po measured after 4 hrs post glucose challenge by OGTT relative to control	Rattus norvegicus	3	ALA4725317	organism-based format	Scientific Literature
15.	ALA4727629	Functional	In vivo inhibition of SGLT1/2 in overnight fasted Sprague-Dawley rat assessed as amount of urinary glucose excretion assessed per 4 hrs at 1 mg/kg, po	Rattus norvegicus	2	ALA4725317	organism-based format	Scientific Literature
16.	ALA4727630	Functional	In vivo inhibition of SGLT1/2 in overnight fasted Sprague-Dawley rat assessed as amount of urinary glucose excretion assessed per 4 hrs at 10 mg/kg, po	Rattus norvegicus	2	ALA4725317	organism-based format	Scientific Literature
17.	ALA4727631	Functional	In vivo inhibition of SGLT1/2 in overnight fasted po dosed Sprague-Dawley rat assessed as reduction in blood glucose by OGTT	Rattus norvegicus	2	ALA4725317	organism-based format	Scientific Literature